New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer – Drug Discovery & Development
|
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
Drug Discovery & Development Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney … |
